EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications

Thomas Volatier iD, Claus Cursiefen iD, Maria Notara

Cells · 16.01.2024 · 13 (2) · 163

DOI: 10.3390/cells13020163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 16.01.2024. Verfasst von Thomas Volatier und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany. Hauptthemen laut MEDLINE: Cornea, Exosomes. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 153 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal stromal stem cells (CSSCs) are of particular interest in regenerative ophthalmology, offering a new therapeutic target for corneal injuries and diseases. This review provides a comprehensive examination of CSSCs, exploring their anatomy, functions, and role in maintaining corneal integrity. Molecular markers, wound healing mechanisms, and potential therapeutic applications are discussed. Global corneal blindness, especially in more resource-limited regions, underscores the need for innovative solutions. Challenges posed by corneal defects, emphasizing the urgent need for advanced therapeutic interventions, are discussed. The review places a spotlight on exosome therapy as a potential therapy. CSSC-derived exosomes exhibit significant potential for modulating inflammation, promoting tissue repair, and addressing corneal transparency. Additionally, the rejuvenation potential of CSSCs through epigenetic reprogramming adds to the evolving regenerative landscape. The imperative for clinical trials and human studies to seamlessly integrate these strategies into practice is emphasized. This points towards a future where CSSC-based therapies, particularly leveraging exosomes, play a central role in diversifying ophthalmic regenerative medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CorneaExosomesHumansCorneal StromaRejuvenationEpigenomics

Stichwörter der Autor:innen

UV-lightcornealimbal stem cellsregenerative ophthalmologystem cells

Autor:innen und Institutionen

  • Department of Ophthalmology, Faculty of Medicine, University Hospital Cologne, University of Cologne, 50937 Cologne, Germany.
  • Cologne Excellence Cluster for Cellular Stress Responses Aging-Associated Diseases (CECAD), University of Cologne, Joseph-Stelzmann-Strasse 26, 50931 Cologne, Germany.
  • Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University Hospital Cologne, University of Cologne, 50931 Cologne, Germany.

ORCID-Profile: Thomas Volatier, Claus Cursiefen

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Volatier, T., Cursiefen, C., & Notara, M. (2024). Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications. Cells, 13(2), 163. https://doi.org/10.3390/cells13020163

Vancouver

Volatier T, Cursiefen C, Notara M. Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications. Cells. 2024;13(2):163. doi:10.3390/cells13020163

BibTeX
@article{Volatier2024,
  author = {Volatier, Thomas and Cursiefen, Claus and Notara, Maria},
  title = {Current Advances in Corneal Stromal Stem Cell Biology and Therapeutic Applications},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {2},
  pages = {163},
  doi = {10.3390/cells13020163}
}
Kostenlos starten →